In Vivo B cell depletion with rituximab reduces the incidence of post-transplant lymphoproliferative disorders after allogeneic stem cell transplantation: a single centre experience between 2000 and 2015 / Amico, L; Ruggeri, L; Falzetti, F; Zei, T; De Carolis, L; Terenzi, A; Aversa, Franco; Bozza, S; Castronari, R; Caniglia, M; Velardi, A; Carotti, A.. - In: BONE MARROW TRANSPLANTATION. - ISSN 0268-3369. - 51:(2016), pp. 34-34. (Intervento presentato al convegno 42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation tenutosi a Valencia, SPAIN nel APR 2016).
In Vivo B cell depletion with rituximab reduces the incidence of post-transplant lymphoproliferative disorders after allogeneic stem cell transplantation: a single centre experience between 2000 and 2015
AVERSA, Franco;
2016-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
